![MBL](https://products.mblintl.com/wp-content/uploads/2023/12/Screenshot3.png)
QuickSwitch™ Quant HLA-A*02:01-PE and Peptides Bundle 1
The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.
Target: SARS-CoV-2 ORF1ab (3122-3130), SARS-CoV-2 ORF1ab (3183-3191), SARS-CoV-2 ORF1ab (3710-3718), SARS-CoV-2 ORF1ab (3732-3740), SARS-CoV-2 ORF1ab (6419-6427), SARS-CoV-2 ORF1ab (6749-6758), SARS-CoV-2 ORF1ab (6851-6859), SARS-CoV-2 ORF3a protein (139-147)
Product Type: Peptide, Tetramer
Application: FCM
Class: Class I
Species Reactivity: Human
Peptide Sequence: FLAHIQWMV, FLLNKEMYL, LLLDDFVEII, LLYDANYFL, SMWALIISV, TLMNVLTLV, YLDAYNMMI, YLNTLTLAV
Research Area: Immunology, Immune Monitoring
Protocols: FCM
Regulatory Statement: For Research Use Only. Not for use in diagnostic procedures.
![QuickSwitch™ Quant HLA-A*02:01-PE and Peptides Bundle 1](https://products.mblintl.com/wp-content/uploads/2023/11/210419_QuickSwitch-Technology.png)